SUMMARY The effect of Rowachol (200 mg tid), an essential oil preparation, on biliary lipid secretion and serum lipids was measured in six healthy male volunteers before and after four weeks of treatment. Biliary cholesterol and phospholipid secretion increased significantly from 113±36 (SD) ,umol/h to 155±52 ,umol/h (p<0.05) and from 409±145 ,umol/h to 587±185 ,umol/h (p<O.05), respectively. Bile acid secretion increased from 1519±662 ,mol/h to 2287±1175
Methods

EXPERIMENTAL DESIGN
Six healthy young male volunteers were studied as outpatients at the Metabolic Unit, Department of Medicine, University of Bonn. The study was conducted in accordance with the principles of the Helsinki declaration and informed consent was obtained from each subject. None of the subjects had evidence of gastrointestinal disease and routine liver function tests were normal. Age, body weight, and height are given in Table 1 . During the study period each subject was on his usual diet and no changes in body weight occurred.
Biliary lipid secretion rates were measured before Storage of the proximal samples and separation of bile acids from cholesterol and phospholipids were performed according to the method used in the National Cooperative Gallstone Study. 13 Ten millilitres of the distal samples were added to ethanol. In every proximal and distal sample, cholesterol and beta-sitosterol were measured by gas liquid chromatography as trimethylsilylethers 4 using 5-alpha-cholestane as internal standard. In every proximal sample bile acids were determined enzymatically15 16 Table 2 . Biliary cholesterol secretion averaged 113 umol/h during control period and increased after administration of Rowachol by 37% to 155 gmol/h (p<005). Biliary secretion of phospholipids averaged 409 ,umol/h during control period and increased significantly by 36% to 587 ,mol/h during Rowachol treatment (p<005). The average increase in bile acid secretion from 1519 ,mol/h to 2287 gmol/h (51%) was not significant (p>005 and <0.10). Administration of Rowachol had no effect on molar composition of cholesterol, bile acids, phospholipids or the lithogenic index (Table 3) . Molar ratios of cholesterol to bile acids, cholesterol to phospholipids and phospholipids to bile acids during the control period averaged 0 09±0 03, 0 29±0 09 and 0-28+0 07, respectively. Administration of Rowachol did not alter these ratios (0-08±0-03, 0 27±0 05 and 0-29±0-09, respectively). No change in the molar composition of individual bile acids was observed during administration of Rowachol, except for lithocholic acid, the smallest fraction, which increased (Table   4) . 133±43  579±92  582±269  1484±252  1845±894  2  90±14  141±22  253±65  673±173  913±177  2752±548  3  122±17  155±18  590±146  568±117  2689±755  2570±720  4  57±8  119±43  334±149  473±166  1415±240  1090±354  5  151±5  255±41  405±34  884±191  1725±179 The beneficial effects of Rowachol on serum lipids 
